Clinical trial
Effect of Intermittent Infusion Versus Continuous Infusion of Vancomycin on Kidney Failure in Critically Ill Patients: Randomized and Controlled Multicenter Clinical Trial.
NCT03438214 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Intermittent Infusion Versus Continuous Infusion of Vancomycin on Kidney Failure in Critically Ill Patients: Randomized and Controlled Multicenter Clinical Trial.
- Lead sponsor
- University of Sao Paulo
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- April 28, 2018
- Completion date
- December 1, 2022
- Enrollment
- 222 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gram-positive bacterial infections, nephrotoxicity, sepsis